UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Can Unmet Needs Be Addressed by Adjunctive Therapies? Findings from a Patient Perspectives Survey in Adults with Type 1 Diabetes

Journal of patient experience, 2024-01, Vol.11, p.23743735241257811-23743735241257811

2024

Volltextzugriff (PDF)

Multifocal insulinoma secondary to insulinomatosis: persistent hypoglycaemia despite total pancreatectomy

Endocrinology, diabetes & metabolism case reports, 2020-12, Vol.2020 (1), p.1-5

2020

Volltextzugriff (PDF)

Sodium–glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection?

Medical journal of Australia, 2022-08, Vol.217 (3), p.126-128

2022

Volltextzugriff (PDF)

Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?

Trends in endocrinology and metabolism, 2020-02, Vol.31 (2), p.150-164

2020

Volltextzugriff (PDF)

Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): Study protocol of a phase 2 double-blinded randomised placebo-controlled trial

Diabetic medicine, 2024-06, Vol.41 (10), p.e15377-e15377

2024

Volltextzugriff (PDF)

Once-Weekly Semaglutide in Adolescents with Obesity

The New England journal of medicine, 2023-03, Vol.388 (12), p.1145-1146

2023

Volltextzugriff (PDF)

Letter to the Editor: “Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry”

The journal of clinical endocrinology and metabolism, 2020-10, Vol.105 (10), p.e3834-e3835

2020

Volltextzugriff (PDF)

Technologies in the management of type 1 diabetes

Medical journal of Australia, 2021-03, Vol.214 (5), p.202-205.e1

2021

Volltextzugriff (PDF)

COVID‐19: it's changed us

Internal medicine journal, 2020-09, Vol.50 (9), p.1162-1163

2020

Volltextzugriff (PDF)

Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657-664

Diabetes care, 2019-08, Vol.42 (8), p.e135-e136

2019

Volltextzugriff (PDF)

Nesidioblastosis following laparoscopic sleeve gastrectomy

Clinical endocrinology (Oxford), 2019-12, Vol.91 (6), p.906-908

2019

Volltextzugriff (PDF)

Insulin resistance in type 1 diabetes managed with metformin (INTIMET): Study protocol of a double‐blind placebo‐controlled, randomised trial

Diabetic medicine, 2021-09, Vol.38 (9), p.e14564-n/a

2021

Volltextzugriff (PDF)

Excess mortality and cardiovascular disease risk in type 1 diabetes

The Lancet (British edition), 2019-03, Vol.393 (10175), p.984-985

2019

Volltextzugriff (PDF)

Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes

The lancet. Gastroenterology & hepatology, 2021-12, Vol.6 (12), p.985-986

2021

Volltextzugriff (PDF)

Massive adrenal hyperplasia from paraneoplastic adrenocorticotropic hormone

BMJ case reports, 2020-04, Vol.13 (4), p.e234892

2020

Volltextzugriff (PDF)

Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin

BMJ open, 2020-10, Vol.10 (10), p.e037859-e037859

2020

Volltextzugriff (PDF)

Letter to the Editor from Snaith et al: “Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry”

The journal of clinical endocrinology and metabolism, 2020-10, Vol.105 (10), p.e3834-e3835

2020

Volltextzugriff (PDF)

OR18-03 Peripheral But Not Hepatic Insulin Resistance Associates With Adverse Vascular And Metabolic Health In Type 1 Diabetes: A Possible Target For Adjunctive Therapy

Journal of the Endocrine Society, 2023-10, Vol.7 (Supplement_1)

2023

Volltextzugriff (PDF)

Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657–664/Response to Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657–664

Diabetes care, 2019-08, Vol.42 (8), p.e135

2019

Volltextzugriff (PDF)

MON-LB113 Insulin Resistance in Type 1 Diabetes Managed With Metformin (INTIMET): Rationale and Study Design of a Randomised Placebo-Controlled Trial

Journal of the Endocrine Society, 2020-05, Vol.4 (Supplement_1)

2020

Volltextzugriff (PDF)

Nesidioblastosis following laparoscopic sleeve gastrectomy

Clinical endocrinology, 2019, Vol.91 (6), p.906-908

2019

Volltextzugriff (PDF)

A Selective Peroxisome Proliferator-Activated Receptor δ Agonist Promotes Reverse Cholesterol Transport

Proceedings of the National Academy of Sciences - PNAS, 2001-04, Vol.98 (9), p.5306-5311

2001

Volltextzugriff (PDF)

Prescribing patterns of adjunctive therapy for the treatment of type 1 diabetes mellitus among Australian endocrinologists

Internal medicine journal, 2024-05, Vol.54 (5), p.779-785

2024

Volltextzugriff (PDF)

Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13

Nature genetics, 2008-10, Vol.40 (10), p.1156-1159

2008

Volltextzugriff (PDF)

Structural studies of the chiral lithium amides [{PhC(H)Me}2NLi] and [PhCH2{PhC(H)Me}NLi·THF] derived from α-methylbenzylamine

Journal of the Chemical Society. Dalton transactions, 1999-01 (22), p.4063-4068

1999

Volltextzugriff (PDF)

1 – 25 von 25

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(23)
Mit Volltextzugriff
(24)

Publikationsform

Artikel
(24)
Berichte
(1)

Sprache

Englisch
(25)

Erscheinungsjahr

n.n

Thema

Science & Technology
(19)
Life Sciences & Biomedicine
(17)
Humans
(11)
General & Internal Medicine
(8)
Medicine, General & Internal
(8)
Cardiovascular Diseases
(6)
Diabetes
(6)
Diabetes Mellitus
(6)
Endocrinology & Metabolism
(6)
Risk Factors
(6)
Adult
(4)
Australia
(4)
Type 1 Diabetes
(4)
Diabetes Mellitus, Type 1
(3)
Female
(3)
Insulin
(3)
Insulin Resistance
(3)
Antidiabetics
(2)
Blood Glucose - Analysis
(2)
Diabetes Mellitus, Type 1 - Drug Therapy
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Can Unmet Needs Be Addressed by Adjunctive Therapies? Findings from a Patient Perspectives Survey in Adults with Type 1 Diabetes

Multifocal insulinoma secondary to insulinomatosis: persistent hypoglycaemia despite total pancreatectomy

Sodium–glucose cotransporter 2 inhibitors in type 1 diabetes: a missed opportunity for cardiovascular protection?

Reducing Type 1 Diabetes Mortality: Role for Adjunctive Therapies?

Reducing cardiometabolic risk with semaglutide in type 1 diabetes (RESET1): Study protocol of a phase 2 double-blinded randomised placebo-controlled trial

Once-Weekly Semaglutide in Adolescents with Obesity

Letter to the Editor: “Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry”

Technologies in the management of type 1 diabetes

COVID‐19: it's changed us

Comment on Braffett et al. Association of Insulin Dose, Cardiometabolic Risk Factors, and Cardiovascular Disease in Type 1 Diabetes During 30 Years of Follow-up in the DCCT/EDIC Study. Diabetes Care 2019;42:657-664

Nesidioblastosis following laparoscopic sleeve gastrectomy

Insulin resistance in type 1 diabetes managed with metformin (INTIMET): Study protocol of a double‐blind placebo‐controlled, randomised trial

Excess mortality and cardiovascular disease risk in type 1 diabetes

Metabolic dysfunction-associated fatty liver disease and insulin resistance in type 1 diabetes

Massive adrenal hyperplasia from paraneoplastic adrenocorticotropic hormone

Rationale and design of a randomised controlled trial testing the effect of personalised diet in individuals with pre-diabetes or type 2 diabetes mellitus treated with metformin

Letter to the Editor from Snaith et al: “Risk Factors for Cardiovascular Disease (CVD) in Adults with Type 1 Diabetes: Findings from Prospective Real-life T1D Exchange Registry”

OR18-03 Peripheral But Not Hepatic Insulin Resistance Associates With Adverse Vascular And Metabolic Health In Type 1 Diabetes: A Possible Target For Adjunctive Therapy

MON-LB113 Insulin Resistance in Type 1 Diabetes Managed With Metformin (INTIMET): Rationale and Study Design of a Randomised Placebo-Controlled Trial

Nesidioblastosis following laparoscopic sleeve gastrectomy

A Selective Peroxisome Proliferator-Activated Receptor δ Agonist Promotes Reverse Cholesterol Transport

Prescribing patterns of adjunctive therapy for the treatment of type 1 diabetes mellitus among Australian endocrinologists

Rheumatoid arthritis susceptibility loci at chromosomes 10p15, 12q13 and 22q13

Structural studies of the chiral lithium amides [{PhC(H)Me}2NLi] and [PhCH2{PhC(H)Me}NLi·THF] derived from α-methylbenzylamine

Suchergebnisse filtern